Ubiquitin like 5 pseudogene 2 (UBL5P2)

Ubiquitin like 5 pseudogene 2 (UBL5P2) is a processed pseudogene located at human chromosome 2:21674324-21674596[1] (though conflicting annotation places another UBL5P2 copy on chromosome 14:72242971-72243238[5]; this reflects potential annotation error or pseudogene multiplicity). It is a retrocopy of the parental gene UBL5, meaning it is derived from UBL5 mRNA that has been reverse transcribed and inserted into the genome. Processed pseudogenes like UBL5P2 typically do not encode functional proteins. They may, in some cases, influence biological processes by producing noncoding RNAs that can regulate other genes (such as via miRNA decoy or siRNA production), but no specific functions or clinical relevance is documented for UBL5P2 itself[2]. UBL5P2 is not considered a receptor, enzyme, transporter, or validated therapeutic target. There are no interacting drugs, mechanisms of action, biomarker applications, or safety concerns associated with UBL5P2 as of current scientific literature or genome annotation databases[4]. Possible annotation issues (chromosomal location and parent gene assignment) and lack of functional or clinical data mean it should not be considered a true therapeutic target.

Other names

UBL5P2Ubiquitin-like 5 pseudogene 2